| 2025 | Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2025 | Noncontrast Magnetic Resonance Imaging vs Ultrasonography for Hepatocellular Carcinoma Surveillance: A Randomized, Single-Center Trial | GASTROENTEROLOGY |
| 2025 | Repurposing of Antiplatelet Agent: Cilostazol for the Treatment of Alcohol-Related Liver Disease
| GUT AND LIVER |
| 2025 | Identification of new biomarkers of hepatic cancer stem cells through proteomic profiling
| Journal of Liver Cancer(대한간암학회지) |
| 2025 | Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma
| CANCERS |
| 2025 | A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B | JOURNAL OF HEPATOLOGY |
| 2025 | Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study
| JHEP REPORTS |
| 2025 | Is liver resection still required for patients who have predictive factors for complete pathologic necrosis after downstaging treatments of locally advanced hepatocellular carcinoma? | EJSO |
| 2024 | Incidence of metabolic dysfunction-associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2024 | Real-world safety and effectiveness of lenvatinib in unresectable hepatocellular carcinoma in Korea: post-marketing study | FUTURE ONCOLOGY |
| 2024 | Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease | GUT |
| 2024 | Agile 3+ and Agile 4 scores predict chronic kidney disease development in metabolic dysfunction-associated steatotic liver disease | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2024 | CHIP ameliorates nonalcoholic fatty liver disease via promoting K63- and K27-linked STX17 ubiquitination to facilitate autophagosome-lysosome fusion
| NATURE COMMUNICATIONS |
| 2024 | Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin Microsphere | CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY |
| 2024 | Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Vibration-controlled transient elastography for significant fibrosis in treatment-naïve chronic hepatitis B patients: A systematic review and meta-analysis
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Risk assessment of hepatitis B virus-related hepato-cellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysis
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Diagnostic accuracy of the Fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: A systematic review and meta-analysis
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Preface
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Assessment of the postoperative prognosis in patients with hepatocellular carcinoma using vibration-controlled transient elastography: A systemic review and meta-analysis
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-analysis
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease | HEPATOLOGY INTERNATIONAL |
| 2024 | Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
| PLOS ONE |
| 2024 | Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis
| JHEP REPORTS |
| 2024 | Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort study | HEPATOLOGY RESEARCH |
| 2024 | Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2024 | Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease | HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL |
| 2024 | Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2024 | Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007-2021: a nationwide, multicentre, retrospective cohort study
| ECLINICALMEDICINE |
| 2024 | Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities
| GUT AND LIVER |
| 2024 | High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2024 | Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| 2024 | Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| 2024 | Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2024 | A Liver Stiffness-Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2024 | Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2024 | Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease | GUT |
| 2024 | A multisociety Delphi consensus statement on new fatty liver disease nomenclature
| ANNALS OF HEPATOLOGY(Annals of Hepatology) |
| 2024 | Fibrotic Burden in Patients With Hepatitis B Virus-Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes | JOURNAL OF INFECTIOUS DISEASES |
| 2024 | Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2024 | PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B | JOURNAL OF HEPATOLOGY |
| 2024 | Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease | GUT AND LIVER |
| 2023 | A multisociety Delphi consensus statement on new fatty liver disease nomenclature
| JOURNAL OF HEPATOLOGY |
| 2023 | Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2023 | Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
| CELL COMMUNICATION AND SIGNALING |
| 2023 | Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
http://orcid.org/0000-0002-9658-8050
(54933821200)
